[9] In the United States it is sold under the brand name Zepbound for weight loss and treatment of obstructive sleep apnea
While semaglutide has demonstrated remarkable efficacy for appetite control and sustainable weight loss, knowing what to expect regarding potential adverse effects helps you make informed decisions and manage your therapy effectively
Participants were at least 18 years of age, spoke English fluently, and were not informed that the study specifically concerned weight, dieting, or GLP-1 medications prior to participation
Do not mix charts
A consumer may instead be looking at a vial, a syringe, or a nasal bottle without the same safeguards
SGLT2 inhibitors were chosen as the comparator given they are guideline-recommended second-line glucose-lowering medication and share similar cardiovascular benefits with GLP-1RA, which helps reduce confounding by indication